162 related articles for article (PubMed ID: 32681963)
21. Effect of cell-penetrating peptides on the nasal absorption of insulin.
Khafagy el-S; Morishita M; Isowa K; Imai J; Takayama K
J Control Release; 2009 Jan; 133(2):103-8. PubMed ID: 18930084
[TBL] [Abstract][Full Text] [Related]
22. Performance and toxicity of different absorption enhancers used in the preparation of Poloxamer thermosensitive in situ gels for ketamine nasal administration.
Xia Y; Li L; Huang X; Wang Z; Zhang H; Gao J; Du Y; Chen W; Zheng A
Drug Dev Ind Pharm; 2020 May; 46(5):697-705. PubMed ID: 32293206
[TBL] [Abstract][Full Text] [Related]
23. CriticalSorb: a novel efficient nasal delivery system for human growth hormone based on Solutol HS15.
Illum L; Jordan F; Lewis AL
J Control Release; 2012 Aug; 162(1):194-200. PubMed ID: 22709592
[TBL] [Abstract][Full Text] [Related]
24. Enhancement Effect of Poly-L-ornithine on the Nasal Absorption of Water-Soluble Macromolecules in Rats.
Omori S; Kamiya Y; Yamaki T; Uchida M; Ohtake K; Kimura M; Natsume H
Biol Pharm Bull; 2019; 42(1):144-148. PubMed ID: 30606986
[TBL] [Abstract][Full Text] [Related]
25. Transport characteristics of a beta sheet breaker peptide across excised bovine nasal mucosa.
Greimel A; Bernkop-Schnürch A; Del Curto MD; D'Antonio M
Drug Dev Ind Pharm; 2007 Jan; 33(1):71-7. PubMed ID: 17192253
[TBL] [Abstract][Full Text] [Related]
26. Effect of aminated gelatin on the nasal absorption of insulin in rats.
Seki T; Kanbayashi H; Nagao T; Chono S; Tomita M; Hayashi M; Tabata Y; Morimoto K
Biol Pharm Bull; 2005 Mar; 28(3):510-4. PubMed ID: 15744079
[TBL] [Abstract][Full Text] [Related]
27. The role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptides.
Khafagy el-S; Morishita M; Takayama K
Int J Pharm; 2010 Mar; 388(1-2):209-12. PubMed ID: 20060451
[TBL] [Abstract][Full Text] [Related]
28. Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts.
Tengamnuay P; Sahamethapat A; Sailasuta A; Mitra AK
Int J Pharm; 2000 Mar; 197(1-2):53-67. PubMed ID: 10704793
[TBL] [Abstract][Full Text] [Related]
29. Quantitative Estimation of the Effect of Nasal Mucociliary Function on in Vivo Absorption of Norfloxacin after Intranasal Administration to Rats.
Inoue D; Kimura S; Kiriyama A; Katsumi H; Yamamoto A; Ogawara KI; Higaki K; Tanaka A; Yutani R; Sakane T; Furubayashi T
Mol Pharm; 2018 Oct; 15(10):4462-4469. PubMed ID: 30165013
[TBL] [Abstract][Full Text] [Related]
30. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
[TBL] [Abstract][Full Text] [Related]
31. Nasal bioavailability of peptide T in rabbits: absorption enhancement by sodium glycocholate and glycofurol.
Bagger MA; Nielsen HW; Bechgaard E
Eur J Pharm Sci; 2001 Aug; 14(1):69-74. PubMed ID: 11457652
[TBL] [Abstract][Full Text] [Related]
32. Correlation of tetradecylmaltoside induced increases in nasal peptide drug delivery with morphological changes in nasal epithelial cells.
Arnold JJ; Ahsan F; Meezan E; Pillion DJ
J Pharm Sci; 2004 Sep; 93(9):2205-13. PubMed ID: 15295781
[TBL] [Abstract][Full Text] [Related]
33. Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers.
Fattah S; Ismaiel M; Murphy B; Rulikowska A; Frias JM; Winter DC; Brayden DJ
Eur J Pharm Sci; 2020 Nov; 154():105509. PubMed ID: 32777258
[TBL] [Abstract][Full Text] [Related]
34. Nasal Drug Absorption from Powder Formulations: Effect of Fluid Volume Changes on the Mucosal Surface.
Tanaka A; Furubayashi T; Enomura Y; Hori T; Shimomura R; Maeda C; Kimura S; Inoue D; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Biol Pharm Bull; 2017; 40(2):212-219. PubMed ID: 28154262
[TBL] [Abstract][Full Text] [Related]
35. Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. II. In vivo nasal absorption of insulin in rats and effects of mixed micelles on the morphological integrity of the nasal mucosa.
Tengamnuay P; Mitra AK
Pharm Res; 1990 Apr; 7(4):370-5. PubMed ID: 2194199
[TBL] [Abstract][Full Text] [Related]
36. Influence of fillers in powder formulations containing N-acetyl-L-cysteine on nasal peptide absorption.
Matsuyama T; Morita T; Horikiri Y; Yamahara H; Yoshino H
J Control Release; 2007 Jul; 120(1-2):88-94. PubMed ID: 17512076
[TBL] [Abstract][Full Text] [Related]
37. Mechanism on antigen delivery under mucosal vaccination using cell-penetrating peptides immobilized at multiple points on polymeric platforms.
Ukawa M; Endo R; Yagi H; Tomono T; Miyata K; Shigeno K; Tobita E; Uto T; Baba M; Sakuma S
Int J Pharm; 2022 Feb; 613():121376. PubMed ID: 34915143
[TBL] [Abstract][Full Text] [Related]
38. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs.
Marttin E; Verhoef JC; Merkus FW
J Drug Target; 1998; 6(1):17-36. PubMed ID: 9769018
[TBL] [Abstract][Full Text] [Related]
39. Analysis of transient and reversible effects of poly-L-arginine on the in vivo nasal absorption of FITC-dextran in rats.
Ohtake K; Natsume H; Ueda H; Morimoto Y
J Control Release; 2002 Aug; 82(2-3):263-75. PubMed ID: 12175742
[TBL] [Abstract][Full Text] [Related]
40. Nose-to-brain delivery of hyaluronate - FG loop peptide conjugate for non-invasive hypoxic-ischemic encephalopathy therapy.
Kim YS; Sung DK; Kim H; Kong WH; Kim YE; Hahn SK
J Control Release; 2019 Aug; 307():76-89. PubMed ID: 31229472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
